ReviewBMC cancer2017

ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.

Nobuaki Mamesaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.